KATELYN ANDERSON: Open Payments
NPI 1346734720 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$583 in 20 payments from 8 companies in 2025. Trend: 2023 $1,057 · 2024 $369 · 2025 $583
Food & beverage: $517Education: $66
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $254 |
| Novartis Pharmaceuticals Corporation | 3 | $99 |
| SANOFI-AVENTIS U.S. LLC | 1 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| PFIZER INC. | 1 | $30 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| Hikma Pharmaceuticals USA | 1 | $14 |
Products named: DUPIXENT, Rhapsido, FASENRA, PANZYGA, NEFFY, Ryaltris.
Industry payments across TN — which companies pay providers there.
